Scott Sandell's Trading History
| COURCoursera | Jun 15, 2026 | Director | Uninformative Buy | ― | $45.02M | |
| KRROKorro Bio | Mar 12, 2026 | Ten Percent Owner | Informative Buy | 2.30M | $18.58M | |
| SGPSpyGlass Pharma | Feb 11, 2026 | Ten Percent Owner | Uninformative Buy | ― | $238.33M | |
| NEUENeueHealth Inc | Oct 06, 2025 | ― | Uninformative Buy | 11.15K | $0.00 | |
| NETCloudflare | Jun 09, 2025 | Director | Uninformative Buy | ― | $62.34M | |
| MBXMBX Biosciences, Inc. | Sep 17, 2024 | Ten Percent Owner | Uninformative Buy | ― | $201.94M | |
| SGMTSagimet Biosciences, Inc. Class A | Jan 31, 2024 | Ten Percent Owner | Uninformative Sell | ― | $29.83M | |
| SVRASavara | Jul 19, 2023 | Ten Percent Owner | Informative Buy | 1.00M | $117.95M | |
| MIRMMirum Pharmaceuticals | Jun 15, 2023 | Ten Percent Owner | Uninformative Sell | ― | $186.95M | |
| CBIOCrescent Biopharma | Jan 27, 2023 | Ten Percent Owner | Informative Sell | 11.46M | $66.96M | |
| ACLXArcellx Inc | Dec 27, 2022 | ― | Informative Sell | 12.35K | $546.18M | |
| AKUSAKOUOS | Dec 02, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| IONQIonQ | Nov 18, 2022 | Ten Percent Owner | Uninformative Sell | ― | $439.35M | |
| AVEOAVEO Pharma | Oct 21, 2022 | ― | Uninformative Sell | ― | $53.38K | |
| GNCAQGenocea Biosciences | May 26, 2022 | ― | Informative Sell | 711.52K | ― | |
| HOODRobinhood | May 16, 2022 | Director | Informative Sell | 73.94K | $2.03B | |
| TRVITrevi Therapeutics | Apr 13, 2022 | Ten Percent Owner | Informative Buy | 6.80M | $154.18M | |
| BEBloom Energy | Apr 01, 2022 | Director | Uninformative Buy | 23.74K | $11.33M | |
| ARDXArdelyx | Dec 27, 2021 | Ten Percent Owner | Informative Sell | 3.63M | $32.58M | |
| MTCRMetacrine | Dec 27, 2021 | ― | Informative Sell | 493.91K | $1.49M | |
| GLUEMonte Rosa Therapeutics | Jun 30, 2021 | Ten Percent Owner | Uninformative Buy | ― | $82.77M | |
| EAREargo | May 26, 2021 | ― | Uninformative Sell | ― | $11.62M | |
| SPTSprout Social | Nov 17, 2020 | Ten Percent Owner | Uninformative Sell | ― | $39.40M | |
| MRSNMersana Therapeutics | Sep 16, 2020 | ― | Uninformative Sell | ― | $173.63M | |
| INZYInozyme Pharma | Jul 28, 2020 | ― | Uninformative Buy | ― | $9.75M | |
| NKTXNkarta | Jul 16, 2020 | Ten Percent Owner | Uninformative Buy | ― | $4.53M | |
| ADAPYAdaptimmune Therapeutics | Jan 28, 2020 | Ten Percent Owner | Informative Buy | 4.95M | $2.36M | |
| RGLSRegulus | May 09, 2019 | ― | Informative Buy | 1.23M | $16.75M | |
| TSROTesaro | Jan 22, 2019 | ― | Uninformative Sell | 781.54M | $0.00 | |
| ESTCElastic | Oct 10, 2018 | Ten Percent Owner | Uninformative Buy | ― | $618.07M | |
| LQDALiquidia Technologies | Aug 01, 2018 | Ten Percent Owner | Uninformative Buy | ― | $111.97M | |
| MULEMulesoft Inc | May 09, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| SURFSurface Oncology | Apr 23, 2018 | ― | Uninformative Buy | ― | $3.54M | |
| TCONTRACON Pharmaceuticals | Mar 27, 2018 | ― | Informative Buy | 1.91M | $110.91K | |
| CASCCascadian Therapeutics | Mar 13, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| ORKAOruka Therapeutics | Feb 27, 2018 | Ten Percent Owner | Informative Sell | 730.10K | $0.00 | |
| APPNAppian | Feb 15, 2018 | Ten Percent Owner | Uninformative Buy | ― | $781.97K | |
| SYBXSynlogic | Jan 26, 2018 | Ten Percent Owner | Uninformative Buy | 4.00M | $4.06M | |
| CRCMCare | Nov 08, 2017 | ― | Uninformative Sell | ― | $33.88M | |
| AKAOQAchaogen | Dec 19, 2016 | ― | Informative Buy | 6.75M | $117.88K | |
| EPZMEpizyme | Jan 12, 2016 | ― | Informative Buy | 10.00M | $9.20M | |
| SUPNSupernus Pharmaceuticals | Nov 12, 2015 | Ten Percent Owner | Uninformative Sell | ― | $8.91M | |
| VTAEVitae Pharma | Jul 02, 2015 | ― | Uninformative Sell | ― | $11.68K | |
| HPTXHyperion Therapeutics | May 11, 2015 | ― | Uninformative Sell | 109.67M | ― | |
| BOXBox | Jan 22, 2015 | Ten Percent Owner | Informative Buy | ― | $7.07M | |
| DATATableau | Dec 08, 2014 | ― | Informative Sell | 1.40M | $9.44M | |
| ~DERMDermira | Oct 08, 2014 | ― | Uninformative Buy | ― | $65.68M | |
| VIRXViracta Therapeutics | Aug 29, 2014 | ― | Informative Sell | 2.13M | $46.59K | |
| LOXOLoxo Oncology | Aug 06, 2014 | ― | Uninformative Buy | ― | $419.91M | |
| ROKASorrento Tech Inc | Jul 22, 2014 | ― | Uninformative Buy | ― | $2.09M | |
| ~HIVEAerohive Networks | Apr 03, 2014 | ― | Uninformative Buy | ― | $20.75M | |
| WDAYWorkday | Mar 04, 2014 | Director | Informative Sell | 535.43K | $1.01M | |
| WIFIBoingo Wireless | Dec 12, 2013 | ― | Uninformative Buy | ― | $0.00 | |
| GYREGyre Therapeutics | Dec 05, 2013 | Ten Percent Owner | Informative Sell | 5.13K | $20.79M | |
| ADNCAudience Inc | Nov 06, 2013 | ― | Uninformative Sell | ― | ― | |
| XOOMXoom Corp | Oct 31, 2013 | ― | Uninformative Sell | ― | ― | |
| GRPNGroupon | Sep 17, 2013 | Ten Percent Owner | Uninformative Sell | ― | $649.85K | |
| CLVSQClovis Oncology | Jun 05, 2013 | ― | Uninformative Sell | ― | $37.24 | |
| MMMillennial Media | Oct 30, 2012 | ― | Informative Sell | 21.47M | $14.34M | |
| INWKInnerWorkings | Mar 30, 2012 | ― | Uninformative Sell | ― | $44.85K | |
| ~~ECHOEcho Global Logistics | Mar 01, 2012 | ― | Uninformative Sell | ― | $43.46K | |
| FIOFusion-IO | Jun 07, 2011 | ― | Informative Buy | ― | ― | |
| ~VGVonage Holdings | Mar 15, 2011 | ― | Uninformative Sell | ― | $478.43K | |
| PRTKParatek Pharmaceuticals | Feb 03, 2009 | ― | Uninformative Buy | ― | $4.65M | |
| ECOMChannelAdvisor | ― | ― | ― | $0.00 | ||
| OMTHOmthera | ― | ― | ― | ― | ||
| ARDMQAradigm | ― | ― | ― | $150.37 |
You May Also Like
Scott Sandell insider profile FAQ
What is the percentage of profitable transactions made by Scott Sandell?
The percentage of profitable transactions made by Scott Sandell is 28%.
What is the average return per transaction made by Scott Sandell?
The average return per transaction made by Scott Sandell is -21.20%.
What stocks does Scott Sandell hold?
Scott Sandell holds: COUR, AVEO, CASC, TSRO, RGLS, GNCAQ, AKAOQ, ADAPY, SYBX, MULE, SVRA, APPN, MRSN, SURF, BE, LQDA, ESTC, TRVI, MIRM, NET, KRRO, SPT, AKUS, NKTX, INZY, MTCR, EAR, IONQ, NEUE, GLUE, HOOD, ACLX, SGMT, MBX, SGP, ORKA, CBIO, ARDX, TCON, DATA, SUPN, BOX, VTAE, HPTX, ~DERM, LOXO, ~HIVE, GYRE, CRCM, MM, EPZM, ROKA, VIRX, WDAY, CLVSQ, GRPN, ~VG, INWK, XOOM, ARDMQ, ~~ECHO, ADNC, WIFI, FIO, PRTK, OMTH, ECOM stocks.
What was Scott Sandell's most profitable transaction?
Scott Sandell’s most profitable transaction was an Informative Buy of CBIO stock on January 9, 2014. The return on the trade was 800.00%.
What is Scott Sandell's role in Coursera?
Scott Sandell's role in Coursera is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.